Ibn (investorbrandnetwork) coverage initiated for silo pharma inc.

New york, march 30, 2022 (globe newswire) -- via investorwire – silo pharma inc. (otcqb: silo), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announces it has selected the corporate communications expertise of ibn (investorbrandnetwork), a multifaceted financial news and publishing company for private and public entities.
SILO Ratings Summary
SILO Quant Ranking